From the WHO on AMR: http://www.who.int/antimicrobial-resistance/en/
Antimicrobial resistance (AMR) is the ability of a microorganism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others.
PhRMA's submission (7 February 2014, USTR-2013-0040) to USTR's 2014 Special 301 Review requested USTR to have "Brazil remain on the Priority Watch List for the 2014 Special 301 Report" expressing concerns over Brazilian patentability standards, regulatory data protection, patent term adjustment for mailbox patents and government price controls and taxation.
The Biotechnology Industry Organization (BIO) submission (7 February 2014, USTR-2013-0040) to USTR's 2014 Special 301 Review requested USTR to place Brazil on the Priority Watch List.
The National Association of Manufacturers's (NAM) submission (7 February 2014, USTR-2013-0040) to USTR's 2014 Special 301 Review expressed concerns with aspects of Brazilian IPR policy including patent backlogs, ANVISA's role in reviewing patents for pharmaceuticals, protection of test data for pharmaceuticals and Brazil's role in WIPO advancing the use of compulsory licensing and requesting WIPO to develop a manual on the use of exceptions and limitations to the rights conferred by patents.
The U.S. Chamber of Commerce's (Global Intellectual Property Center) submission (7 February 2014, USTR-2013-0040) to USTR's 2014 Special 301 expressed concerns with aspects of Brazilian IP policy which included the role of ANVISA in the granting of patents, patentability criteria, test data protection, compulsory licensing and local content requirements for cable television.
Microsoft meeting with US Ambassador to Brazil regarding politics of Open Document Format (ODF) proposal to ISOSubmitted by James Love on 4. September 2011 - 16:56
On December 21, 2007, the U.S. Consul General for São Paulo, Thomas White, wrote a cable titled: MICROSOFT SEES GOB ATTACKS AGAINST IPR. The cable was classified by James Story, the Econ/Pol Chief.
|Ambassador Clifford Sobel (photo from Wikimedia)|
BRICS Health Ministers’ preparatory meeting – May 17th 2011
Consistent with the mandate of the Sanya Declaration of the BRICS Leaders Meeting (14 April 2011), the Ministers of Health of the five BRICS’ countries met on the sidelines of the 64thWorld Health Assembly, on 17 May 2011, to discuss issues of common interest as well as prepare the BRICS Health Ministerial Meeting to be held in Beijing, China, on 11 July 2011. Representatives of WHO and UNAIDS also attended the meeting.
64TH WORLD HEALTH ASSEMBLY
The future of financing for WHO A64/4
WHO REFORM AGENDA
Provisional agenda item 11
STATEMENT BY THE BRAZILIAN DELEGATION
At the outset we would like to thank the report by the Director-General on WHO reform and its future financing for a healthy future. We acknowledge the efforts to reflect comments and suggestions presented by Member-States throughout the ongoing consultation process and believe the document is a good basis for our continued debate on this important issue.